Some peptides, such as peptide YY (PYY) and glucagon-like peptide-1 (GLP-1), are known to have appetite-suppressing effects by signaling to the brain that you are full or by delaying gastric emptying
The following section covers milestones and important updates
In April 2025, according to an article published by the Heart Rhythm Society, a recent clinical study, TRANSFORM-AF, found that GLP-1 receptor agonists (GLP-1 RAs), typically used for diabetes, may reduce atrial fibrillation (AF)-related events in patients with both obesity and AF
Which pages should procurement buyers review
The FTC report found instances where PBMs reimbursed their own affiliated pharmacies at rates substantially higher than they paid independent pharmacies for the same drugs
Additional information The Avata Standard of Excellence Third-Party Tested Every batch independently verified by HPLC and mass spectrometry